Vivos Therapeutics, Inc.
Vivos Therapeutics, Inc. (VVOS) is a publicly traded company in the Unknown sector. Across all available filings, 2 corporate insiders have executed 15 transactions totaling $136.2K, demonstrating a bullish sentiment with $136.2K in net insider flow. The most recent transaction on Jun 20, 2023 involved a purchase of 14,000 shares valued at $7.4K.
VVOS Insider Activity Summary
Who Is Buying VVOS Stock?
No significant insider buying has been recorded for VVOS in the recent period.
Who Is Selling VVOS Stock?
No significant insider selling has been recorded for VVOS in the recent period.
Is Vivos Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for VVOS is bullish with an Insider Alignment Score of 100/100 and a net flow of $136.2K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
VVOS Frequently Asked Questions
Understanding VVOS Insider Activity
Insider trading at Vivos Therapeutics, Inc. (VVOS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 2 insiders are actively trading VVOS stock, having executed 15 transactions in the past 90 days. The most active insider is Ronald Kirk Huntsman (Executive), who has made 12 transactions totaling $116.3K.
Related Tools
Track Vivos Therapeutics, Inc. Insider Activity
Get notified when executives and directors at VVOS file new Form 4 transactions